Yasuhiro Choda

Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial

Yoon‐Koo Kang, Li‐Tzong Chen, Min‐Hee Ryu et al. · The Lancet Oncology · 2022 · 768 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in advanced gastrointestinal cancer patients with cancer cachexia

Satoshi Hamauchi, Junji Furuse, Toshimi Takano et al. · Cancer · 2019 · 161 citations · Full text

Medicine, Oncology, Pharmacology +17

Four courses versus eight courses of adjuvant S-1 for patients with stage II gastric cancer (JCOG1104 [OPAS-1]): an open-label, phase 3, non-inferiority, randomised trial

Takaki Yoshikawa, Masanori Terashima, Junki Mizusawa et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 113 citations

Medicine, Oncology, Surgery +11

Multicenter retrospective study to evaluate the efficacy and safety of the double‐flap technique as antireflux esophagogastrostomy after proximal gastrectomy (<scp>rD</scp>‐<scp>FLAP</scp> Study)

Shinji Kuroda, Yasuhiro Choda, S. Otsuka et al. · Annals of Gastroenterological Surgery · 2018 · 108 citations · Full text

Medicine, Plastic Surgery, Surgery +16

Experience in 100 cases with the Nuss procedure using a technique for stabilization of the pectus bar

Sadashige Uemura, Yoshikiyo Nakagawa, Atsushi Yoshida et al. · Pediatric Surgery International · 2003 · 73 citations

Medicine, Orthopaedic Surgery, Surgery +6